Semaglutide activates GLP-1 receptors in your brain and digestive system, decreasing appetite and slowing stomach emptying to create lasting satiety
Rapid weight loss, while sometimes appealing, is associated with a higher risk of muscle loss, nutritional deficiencies, gallstones, and difficulty maintaining the weight loss long-term
KET01-02 was a placebo-controlled, double-blind phase 2 RCT conducted between May 2022 and May 2023 among adult outpatients (aged 18 years) with treatment-resistant depression across 29 trial sites in the Czech Republic, Germany, and Poland
Additionally, if any impacted Wellstar team member wants to continue serving the East Point community, Wellstar and Southsides human resource teams will collaborate to offer them opportunities at Southside Medical Center locations